Literature DB >> 11513834

Baicalein induces a dual growth arrest by modulating multiple cell cycle regulatory molecules.

S L Hsu1, Y C Hsieh, W C Hsieh, C J Chou.   

Abstract

Baicalein, a flavonoid present in the root of Scutellaria baicalensis Georgi, has been reported to inhibit cell proliferation in several types of cells. In this study, the effect of baicalein on cell growth and the mechanism of growth modulation were examined in primary cultured rat heart endothelial cells. Here, we report that treatment with 100-microM baicalein caused an almost complete inhibition of cell proliferation after 5 days of incubation. Baicalein mediated G1 and G2 growth arrest accompanied by the down-regulation of cyclin D2, cyclin A, cyclin-dependent kinase 1 (Cdk1) and cyclin-dependent kinase 2 (Cdk2), and up-regulation of p15(Ink4B), p21(CIP1/Waf1), p53 and cyclin E. Evaluation of the kinase activity of cyclin-Cdk complexes showed that baicalein decreased Cdk1, Cdk2, cyclin D2 and cyclin A expression in endothelial cells, leading to markedly reduced Cdk/cyclin-associated kinase activities. These results suggest that baicalein inhibits the proliferation of rat heart endothelial cells via G1 and G2 arrest in association with the down-regulation of the expression and function of Cdk1, Cdk2, cyclin D2 and cyclin A proteins, and up-regulation of cyclin E, p15(Ink4B), p53 and p21(CIP1/Waf1).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11513834     DOI: 10.1016/s0014-2999(01)01144-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells.

Authors:  Yujun Wang; Ernest Han; Quanhua Xing; Jin Yan; Amanda Arrington; Charles Wang; Dylan Tully; Claudia M Kowolik; David M Lu; Paul H Frankel; Jing Zhai; Wei Wen; David Horne; M L Richard Yip; John H Yim
Journal:  Cancer Lett       Date:  2014-12-25       Impact factor: 8.679

2.  The lipoxygenase inhibitor, baicalein, modulates cell adhesion and migration by up-regulation of integrins and vinculin in rat heart endothelial cells.

Authors:  Y-C S Hsieh; S-J Hsieh; Y-S Chang; C-M Hsueh; S-L Hsu
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

3.  Inhibitory effects of 5,6,7-trihydroxyflavones on tyrosinase.

Authors:  Hong Gao; Jun Nishida; Shizuka Saito; Jun Kawabata
Journal:  Molecules       Date:  2007-01-29       Impact factor: 4.411

4.  Baicalein Activates Parkin-Dependent Mitophagy through NDP52 and OPTN.

Authors:  Po-Yuan Ke; Chih-Wei Chang; Yuan-Chao Hsiao
Journal:  Cells       Date:  2022-03-28       Impact factor: 7.666

5.  The flavonoid apigenin downregulates CDK1 by directly targeting ribosomal protein S9.

Authors:  Yosuke Iizumi; Masakatsu Oishi; Tomoyuki Taniguchi; Wakana Goi; Yoshihiro Sowa; Toshiyuki Sakai
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

6.  Analysis of the interactions of botanical extract combinations against the viability of prostate cancer cell lines.

Authors:  Lynn S Adams; Navindra P Seeram; Mary L Hardy; Catherine Carpenter; David Heber
Journal:  Evid Based Complement Alternat Med       Date:  2006-03       Impact factor: 2.629

7.  BA-j as a novel CDK1 inhibitor selectively induces apoptosis in cancer cells by regulating ROS.

Authors:  Shixuan Zhang; Yongming Bao; Xiulan Ju; Kangjian Li; Haiyan Shang; Lisha Ha; Yuan Qian; Liang Zou; Xiaodan Sun; Jing Li; Qianru Wang; Qingyu Fan
Journal:  Sci Rep       Date:  2015-09-02       Impact factor: 4.379

8.  Use of Baicalin-Conjugated Gold Nanoparticles for Apoptotic Induction of Breast Cancer Cells.

Authors:  Donghyun Lee; Wan-Kyu Ko; Deok-Sang Hwang; Dong Nyoung Heo; Sang Jin Lee; Min Heo; Kook-Sun Lee; Ji-Yoon Ahn; Junyoung Jo; Il Keun Kwon
Journal:  Nanoscale Res Lett       Date:  2016-08-30       Impact factor: 4.703

9.  Role of Quercetin in Modulating Chloride Transport in the Intestine.

Authors:  Bo Yu; Yu Jiang; Lingling Jin; Tonghui Ma; Hong Yang
Journal:  Front Physiol       Date:  2016-11-23       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.